FLSC CEO Cha Albert Buys $3M of Stock
CEO Cha Albert made a significant purchase of company shares, investing $3 million.
Reviewed by automated data checks against the source filing. How we make and check alerts
Cha Albert, Chief Executive Officer at Frazier Life Sciences Acquisition Corp. II ($FLSC), bought 300,000 shares at an average price of $10, worth about $3 million, on October 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $FLSC is down 1.3% to date (from the $10.49 close on Oct 15, 2026).
FLSC
Frazier Life Sciences Acquisition Corp. II
Key Points
- On October 15, 2026, CEO Cha Albert bought 300,000 shares of Frazier Life Sciences Acquisition Corp. II for $10 each, totaling $3 million.
- The stock recently traded around $10.45 on October 16, 2026, which is above its 50-day and 200-day moving averages by 0.6%.
- Frazier Life Sciences Acquisition Corp. II, focused on business combinations, has a market cap of about $100.1 million.
Get $FLSC trade alerts by text
We text you when insiders, Congress or big funds trade $FLSC. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Frazier Life Sciences Acquisition Corp. II alert may contain errors. Disclosures
CEO Cha Albert of Frazier Life Sciences Acquisition Corp. II bought 300,000 shares on October 15, 2026, for $10 each, totaling $3 million. This purchase shows his confidence in the company as it seeks to make significant business combinations.
Inside Cha Albert's Trade
Cha Albert acquired 300,000 shares in a direct purchase, valued at $3 million. This was not a planned sale, indicating a personal investment in the company.
Frazier Life Sciences Acquisition Corp. II Stock Down 0.4%
The stock recently traded around $10.45 as of October 16, 2026. This price is above both its 50-day and 200-day moving averages by 0.6%. However, it is slightly below its 52-week high of $10.59, suggesting some room for growth.
About Frazier Life Sciences Acquisition Corp. II
Frazier Life Sciences Acquisition Corp. II, based in Palo Alto, California, focuses on merging or acquiring other businesses. Incorporated in 2026, it operates within the financial services sector, specifically as a shell company.
Bottom Line
Investors should monitor any future developments from Frazier Life Sciences Acquisition Corp. II, particularly as the company progresses with its business combination plans.
Related Filing Alerts
Source: Cha Albert's Form 4 filing on $FLSC (Oct 15, 2026). Find the original filing: FLSC Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts